AppFolio extends contract with large property manager
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Meissner building $250M Georgia plant
Camarillo-based life sciences firm Meissner Corporation is planning to build a second, nearly $250 million manufacturing facility in the United States. The facility will be in Athens-Clarke County, Georgia, which has a modest biotech hub. The project, which the company says is expected to create more than 1,700 jobs over the next eight years, was Read More →
Avocado pricing hurts Calavo’s first quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Analyst remains confident in Inogen despite huge selloff
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AeroVironment revenue exceeds expectations in the third quarter
AeroVironment, headquartered in Virginia but still maintains operations in Simi Valley and Moorpark, saw a huge bump in revenue when the company released its earnings results for the third quarter after the markets closed March 6. A maker of drones, AeroVironment reported revenue worth $134.4 million for the quarter ended Dec. 31, an increase of Read More →
MannKind delivers record revenue
MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, delivered a record year for revenue behind its multiple products out in the market. Based in Westlake Village, MannKind generated revenue worth $99.7 million in 2022, up from $75.2 million in 2021. In the fourth quarter, revenue also shot up to $36 Read More →
Arcutis gearing up for active 2023
Arcutis Biotherapeutics generated sales from its first treatment during the fourth quarter of 2022, helping usher in a new era for the company. Based in Westlake Village, Arcutis recognized $3 million in revenue for the quarter that ended Dec. 31, all of it coming from its Zoryve cream aimed to treat plaque psoriasis. For the Read More →
